Warning message will be there |
Did you mean: ht screening hts
| All | Review |
| Items 1-20 of 31 |
|
1 2 Next |
|
1:
|
Development and validation of a high-throughput screening assay for human long-chain fatty acid transport proteins 4 and 5.
J Biomol Screen. 2010 Jun;15(5):488-97
PMID: 20448275 [PubMed - in process]
|
|
2:
|
Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation.
Stroke. 2010 Mar;41(3):e135-42
PMID: 20075362 [PubMed - indexed for MEDLINE]
|
|
3:
|
A novel high-throughput screening assay for HCN channel blocker using membrane potential-sensitive dye and FLIPR.
J Biomol Screen. 2009 Oct;14(9):1119-28
PMID: 19773585 [PubMed - indexed for MEDLINE]
|
|
4:
|
Multiplexed flow cytometry: high-throughput screening of single-chain antibodies.
Methods Mol Biol. 2009;525:241-60, xiii
PMID: 19252858 [PubMed - indexed for MEDLINE]
|
|
5:
|
Treatment and prophylaxis of cardiac allograft vasculopathy.
Transplant Proc. 2008 Oct;40(8):2609-10
PMID: 18929815 [PubMed - indexed for MEDLINE]
|
|
6:
|
Rectal hepatoid carcinoma with liver metastases in a patient affected by ulcerative colitis.
Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):539-43
PMID: 18842504 [PubMed - indexed for MEDLINE]
|
|
7:
|
Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
Comb Chem High Throughput Screen. 2008 May;11(4):316-24
PMID: 18473741 [PubMed - indexed for MEDLINE]
|
|
8:
|
Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulators.
Assay Drug Dev Technol. 2008 Apr;6(2):167-79
PMID: 18078380 [PubMed - indexed for MEDLINE]
|
|
9:
|
Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions.
Eur J Histochem. 2007 Jul-Sep;51(3):193-8
PMID: 17921114 [PubMed - indexed for MEDLINE]
|
|
10:
|
Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats.
Am J Physiol Renal Physiol. 2007 Nov;293(5):F1584-91
PMID: 17715265 [PubMed - indexed for MEDLINE]
|
|
11:
|
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
Menopause. 2007 Nov-Dec;14(6):978-84
PMID: 17595593 [PubMed - indexed for MEDLINE]
|
|
12:
|
Development of a Ca(2+)-activated photoprotein, Photina, and its application to high-throughput screening.
J Biomol Screen. 2007 Aug;12(5):694-704
PMID: 17517900 [PubMed - indexed for MEDLINE]
|
|
13:
|
High-content siRNA screening.
Mol Biosyst. 2007 Apr;3(4):232-40
PMID: 17372651 [PubMed - indexed for MEDLINE]
|
|
14:
|
High-throughput liberation of water-soluble yeast content by irreversible electropermeation (HT-irEP).
J Biomol Screen. 2007 Mar;12(2):267-75
PMID: 17218663 [PubMed - indexed for MEDLINE]
|
|
15:
|
Effect of plasmapheresis for acute humoral rejection after heart transplantation.
Transplant Proc. 2006 Dec;38(10):3692-4
PMID: 17175369 [PubMed - indexed for MEDLINE]
|
|
16:
|
Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Int J Cancer. 2007 Feb 15;120(4):880-4
PMID: 17131324 [PubMed - indexed for MEDLINE]
|
|
17:
|
Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Int J Cancer. 2006 Jun 15;118(12):3112-7
PMID: 16395702 [PubMed - indexed for MEDLINE]
|
|
18:
|
EK-6136 (3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one): a novel Cdc25B inhibitor with antiproliferative activity.
Eur J Pharmacol. 2005 Dec 28;528(1-3):37-42
PMID: 16324698 [PubMed - indexed for MEDLINE]
|
|
19:
|
Continuous monitoring of middle cerebral artery recanalization with transcranial color-coded sonography and Levovist.
J Thromb Thrombolysis. 2005 Feb;19(1):55-9
PMID: 15976968 [PubMed - indexed for MEDLINE]
|
|
20:
|
Hyperhomocysteinemia: an additional risk factor in white coat hypertension.
Int Heart J. 2005 Mar;46(2):245-54
PMID: 15876808 [PubMed - indexed for MEDLINE]
|
| Items 1-20 of 31 |
|
1 2 Next |
Warning message will be there |
